 flow cytometr studi human osteosarcoma number recent studi potenti valu flow cytometri marker malign therefor biolog behavior neoplasm bone tumor propidium iodid home-built flow cytomet author dna distribut patient osteosarcoma percentag cell diploidi s-phase tetraploidi aneuploidi valu deriv dna concentr possibl extent abnorm group neoplasm sever normal pattern data disease-fre surviv total surviv correl weak pattern predict increas risk metastasi death effect treatment pattern chemotherapi surviv like improv technolog flow cytometri valu futur prognosi osteosarcoma treatment effect